Robin Roukens1, Frank Lauster2, Maria Bara3, Bernd Eifert4, Dietrich Willemsen5, Thomas Randall6, Jürgen Herzog7, Constanze Wendt8, Tobias Schmidt-Wilcke1,9, Stefan Knecht10,11,12. 1. Mauritius Therapieklinik, Heinrich-Heine Universität Düsseldorf, Strümper Straße 111, 40670, Meerbusch, Deutschland. 2. Schön Klinik, Bad Aibling, Deutschland. 3. Klinik und Rehabilitationszentrum Lippoldsberg, Wahlsberg, Deutschland. 4. SRH Fachkrankenhaus, Neresheim, Deutschland. 5. DRK-Krankenhaus, Middelburg, Deutschland. 6. Asklepios Kliniken, Schildautal-Seesen, Deutschland. 7. Schön Klinik, München-Schwabing, Deutschland. 8. Labor Dr. Limbach und Kollegen, Heidelberg, Deutschland. 9. Klinische Neurowissenschaften und Medizinische Psychologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland. 10. Mauritius Therapieklinik, Heinrich-Heine Universität Düsseldorf, Strümper Straße 111, 40670, Meerbusch, Deutschland. Stefan.Knecht@stmtk.de. 11. Klinische Neurowissenschaften und Medizinische Psychologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland. Stefan.Knecht@stmtk.de. 12. Hygiene-Kommission der Deutschen Gesellschaft für Neurorehabilitation (DGNR), Meerbusch, Deutschland. Stefan.Knecht@stmtk.de.
Abstract
BACKGROUND AND OBJECTIVES: The number of patients with multiresistant bacteria (MRB) in rehabilitation facilities is increasing. The increasing costs of hygienic isolation measures reduce resources available for core rehabilitation services. In addition to the existing lack of care, patients with MRB are at further risk of being given lower priority for admission to rehabilitation facilities. Therefore, the Hygiene Commission of the German Society for Neurorehabilitation (DGNR) attempted to quantify the overall risk for deterioration of rehabilitation care due to the financial burden of MRB. MATERIALS AND METHODS: To analyze the added costs associated with the rehabilitation of patients with MBR, the DGNR Hygiene Commission identified criteria for a cost assessment. Direct (consumables, personnel and miscellaneous costs) and indirect costs of loss of opportunity were evaluated in seven neurorehabilitation centers in different states across Germany. RESULTS: On average, hygienic isolation measures amounted to direct costs of 144 € per day (47 € consumables, 92 € personnel, 5 € for other costs such as extra transportation expenditure) and indirect costs of 274 €, totaling 418 € per patient with MRB per day. Given that approximately 10% of patients had MRB, the added costs of hygienic isolation measures equaled about one tenth of the overall budget of a rehabilitation center and can be expected to rise with the increasing numbers of patients with MRB. CONCLUSIONS: Admission of patients carrying MRB to neurorehabilitation centers triggers added costs that critically diminish the overall capacity for centers to provide their core rehabilitation services.
BACKGROUND AND OBJECTIVES: The number of patients with multiresistant bacteria (MRB) in rehabilitation facilities is increasing. The increasing costs of hygienic isolation measures reduce resources available for core rehabilitation services. In addition to the existing lack of care, patients with MRB are at further risk of being given lower priority for admission to rehabilitation facilities. Therefore, the Hygiene Commission of the German Society for Neurorehabilitation (DGNR) attempted to quantify the overall risk for deterioration of rehabilitation care due to the financial burden of MRB. MATERIALS AND METHODS: To analyze the added costs associated with the rehabilitation of patients with MBR, the DGNR Hygiene Commission identified criteria for a cost assessment. Direct (consumables, personnel and miscellaneous costs) and indirect costs of loss of opportunity were evaluated in seven neurorehabilitation centers in different states across Germany. RESULTS: On average, hygienic isolation measures amounted to direct costs of 144 € per day (47 € consumables, 92 € personnel, 5 € for other costs such as extra transportation expenditure) and indirect costs of 274 €, totaling 418 € per patient with MRB per day. Given that approximately 10% of patients had MRB, the added costs of hygienic isolation measures equaled about one tenth of the overall budget of a rehabilitation center and can be expected to rise with the increasing numbers of patients with MRB. CONCLUSIONS: Admission of patients carrying MRB to neurorehabilitation centers triggers added costs that critically diminish the overall capacity for centers to provide their core rehabilitation services.
Entities:
Keywords:
Antibiotic resistance; Health economy; Isolation measures; Neurorehabilitation; Rehabilitation
Authors: Melanie Schubert; Daniel Kämpf; Marlena Wahl; Samuel Hofmann; Maria Girbig; Lutz Jatzwauk; Claudia Peters; Albert Nienhaus; Andreas Seidler Journal: Int J Environ Res Public Health Date: 2019-05-13 Impact factor: 3.390